Phathom Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $49,504 | $39,503 | $28,519 | $29,664 |
Gross Profit | 43,314 | 34,465 | 24,795 | 25,849 |
EBITDA | -13,709 | -58,120 | -76,068 | -55,665 |
EBIT | -13,865 | -58,292 | -76,245 | -55,858 |
Net Income | -29,973 | -75,810 | -94,316 | -74,451 |
Net Change In Cash | 49,504 | 39,503 | 28,519 | 29,664 |
Free Cash Flow | -14,115 | -62,729 | -84,948 | -63,461 |
Cash | 135,156 | 149,569 | 212,315 | 297,263 |
Basic Shares | 73,396 | 72,466 | 71,969 | 71,045 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $55,252 | $682 | $0 | $0 |
Gross Profit | 47,279 | 515 | -620 | -521 |
EBITDA | -261,522 | -159,049 | -169,798 | -136,574 |
EBIT | -262,317 | -159,624 | -170,418 | -137,095 |
Net Income | -334,326 | -201,592 | -197,723 | -143,883 |
Net Change In Cash | 55,252 | 682 | 0 | 0 |
Cost of Revenue | -104,237 | |||
Free Cash Flow | -266,905 | -139,214 | -147,571 | -148,785 |
Cash | 297,263 | 381,393 | 155,385 | 183,259 |
Basic Shares | 63,176 | 51,289 | 39,118 | 37,002 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.15 |
2025-06-30 | -$0.79 |
2025-03-31 | -$1.07 |
